Ondansetron
Product Images NDC 53002-0591

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 53002-0591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530020591)

Ondansetron 8 mg oral tablets packaging label from RPK Pharmaceuticals, Inc., displaying a carton containing 10 tablets. The label includes directions to take tablets as prescribed, barcodes, lot number, expiration date, and placeholders for patient and prescriber information. It is labeled Rx only and contains dosing instructions.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure diagram of Ondansetron, showing its molecular framework including an indole ring, a ketone group, and a methyl-substituted triazole ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.